Abstract
Melanoma is a very aggressive cancer, responsable for 80% of all deaths from skin cancer. The weapons for the treatment of melanoma are very scarce and new technologies have been exploited to identify specific molecular targets and ligands. In view of the low efficiency of melanoma therapy owing to its fast growth, metastasis, and resistance to drugs which cause severe side effects, the s…